CSPC Pharmaceutical Group Limited (SEHK:1093) commences share repurchases on November 30, 2021, under the program mandated by the shareholders in the Annual General Meeting held on May 18, 2021. As per the mandate, the company is authorized to repurchase up to 1,197,376,973 shares, representing 10% of its issued share capital. The repurchases will result in an increase in the net asset value and/or earnings per share. The repurchase program will be funded out of funds legally available for the purpose in accordance with its Articles of Association and the Companies Ordinance. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As at May 18, 2021, the company had 11,973,769,732 shares in issue.